Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF
Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF Summary
Product Specifications
Trp28-Ala526, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
10027-AL
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute at 1 mg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
View Larger
When Recombinant Cynomolgus Monkey ALCAM (Catalog # 10027-AL) is coated onto a microplate at 1 µg/mL, Biotinylated Recombinant Human CD6 Fc Chimera binds with an ED50 of 10-50 ng/mL.
View Larger
2 μg/lane of Recombinant Cynomolgus Monkey ALCAM/CD166 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 67-89 kDa.
Reconstitution Calculator
Background: ALCAM/CD166
ALCAM (activated leukocyte cell adhesion molecule), designated CD166, is a 100‑110 kDa type I transmembrane glycoprotein and a member of the Ig CAM family within the immunoglobulin superfamily (1). The cynomologous ALCAM amino acid (aa) sequence includes a signal peptide, an extracellular domain (ECD) with two V‑type and three C2‑type Ig‑like domains, a transmembrane domain and a short cytoplasmic domain (1). Human ALCAM has several isoforms, including an isoform lacking most of the cytoplasmic domain and a secreted isoform (sALCAM) which antagonizes full‑length ALCAM (2, 3). Mature cynomologous ALCAM ECD shares 93% and 96% aa sequence identity with human and mouse/rat ALCAM, respectively. ALCAM is expressed on multiple cell types including thymic epithelium, microvascular endothelium, activated lymphocytes and monocytes, and monocyte‑derived dendritic cells (1, 4). ALCAM mediates low‑affinity adhesion with itself or the cysteine‑rich scavenger receptor CD6 to regulate T cell development, immunological synapses (IS), and cell migration through endothelial junctions (1‑11). ALCAM on thymic epithelia mediates adhesion to CD6 on CD4+CD8+ T cells (6). Adhesion of ALCAM‑expressing antigen presenting cells and CD6‑expressing T cells stabilizes the early IS, while later it enhances CD3 effects on T cell proliferation, CD25 expression, and Th1 commitment (4, 7, 8). High ALCAM expression at the blood‑brain barrier in active multiple sclerosis, and its mouse model (EAE), promotes leukocyte migration to the brain (8, 9). High ALCAM expression on melanoma cell lines appears to be pro‑metastatic, but anti‑metastatic activity has been reported in breast cancer (3, 10, 11). ALCAM may influence expression or adhesion of the neuronal adhesion molecule NCAM‑L1, both in the developing retina and invasive melanoma (2, 12).
- Bowen, M.A. et al. (1995) J. Exp. Med. 181:2213.
- van Kilsdonk, J.W.J. et al. (2008) Cancer Res. 68:3671.
- Ikeda, K. and T. Quertermous (2004) J. Biol. Chem. 279:55315.
- Zimmerman, A.W. et al. (2006) Blood 107:3212.
- van Kempen, L.C. et al. (2001) J. Biol. Chem. 276:25783.
- Castro, M.A.A. et al. (2007) J. Immunol. 178:4351.
- Nair, P. et al. (2010) Clin. Exp. Immunol. 162:116.
- Masedunskas, A. et al. (2006) FEBS Lett. 580:2637.
- Cayrol, R. et al. (2008) Nat. Immunol. 9:137.
- Degen, W.G. et al. (1998) Am. J. Pathol. 152:805.
- King, J.A. et al. (2010) Mol. Cancer 9:266.
- Buhusi, M. et al. (2009) J. Neurosci. 29:15630.
Citation for Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Optimization and Characterization of Novel ALCAM-Targeting Antibody Fragments for Transepithelial Delivery
Authors: Bauer, A;Klassa, S;Herbst, A;Maccioni, C;Abhamon, W;Segueni, N;Kaluzhny, Y;Hunter, MC;Halin, C;
Pharmaceutics
Species: Chinese Hamster
Sample Types: Whole Cells
Applications: Antibody Array Development
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF and earn rewards!
Have you used Recombinant Cynomolgus Monkey ALCAM His-tag Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
